British drug-maker AstraZeneca said it will close its research and development unit in Bangalore, India, making more than 150 jobs redundant.
The move, as part of an ongoing global restructuring exercise, will also shut down its early stage research on tropical diseases tuberculosis and malaria.
The existing research will be moved to its UK facility at Macclesfield or outsourced to a third party, according to the company.
Chosen excerpts by Job Market Monitor. Read the whole story at AstraZeneca to Close India R&D Unit in Global Cost-Cutting Move.
Related Posts
Layoffs in Pharmaceutical Industry / Due to Productivity Crisis in R&D ?
The number of new drugs approved per billion US dollars spent on R&D by the pharmaceutical industry fell by half roughly every 9 years since 1950 Continue reading »
Layoffs in Pharmaceuticals / The top 10 largest in 2013
The patent cliff is often the big culprit. One might think that a one-to-one relationship could be graphed between what is happening with the patent cliff and layoffs, but that is not the case Continue reading »
Austerity in Europe Puts Pressure on Drug Companies
Profits at pharmaceutical companies have been declining or showing little growth for the last year as austerity measures across Europe lead to cuts in health care spending. Some analysts say this trend could continue until at least 2014. Budget cuts mean that many European governments are not willing to pay as much for pills. But … Continue reading »
Job Market Monitor 
Discussion
No comments yet.